IR News Archives IR News Archives

2023

富士製薬工業ウェブサイト、新着情報のバックナンバーです。
各新着情報の文章をクリックしていただくと、詳細情報をご覧いただけます。

  1. latest news
  2. 2026
  3. 2025
  4. 2024
  5. 2023
  6. 2022
  7. 2021
  8. 2020
  9. 2019
  10. 2018
  11. 2017
  12. 2016
  13. 2015
  14. 2014
  15. 2013
  16. 2012
  17. 2011
  18. 2010
  19. 2009
  20. 2008
  21. 2007
  22. 2006
  23. 2005
  24. 2004

latest news

2023.12.11
Financial Results(決算資料)
Script for Business Results Briefing for the Fiscal Year Ended September 30, 2023
2023.11.28
Other(その他)
Notice of the 59th Ordinary General Meeting of Shareholders
2023.11.20
Financial Results(決算資料)
Business Results of FY2023
2023.11.09
Financial Results(決算資料)
Supplemental Materials of FY2023 Consolidated Financial Results
2023.11.09
Financial Results(決算資料)
Financial Results of FY2023
2023.10.18
Release(リリース)
Submission of a Marketing Approval Application for FSN-013 in Japan
2023.09.25
Release(リリース)
Marketing Approval for Ustekinumab Biosimilar
2023.09.06
Release(リリース)
Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen's Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan
2023.08.15
Release(リリース)
Marketing Approval for generic lenalidomide, the first collaboration product with Lotus
2023.08.08
Financial Results(決算資料)
Supplemental Materials of 3Q/FY2023 Consolidated Financial Results
2023.08.08
Financial Results(決算資料)
Financial Results of 3Q/FY2023
2023.06.30
Other(その他)
Corporate Report 2023(English version) has been published
2023.05.26
Financial Results(決算資料)
Script for Q2 Financial Results Briefing for the Fiscal Year Ending September 2023
2023.05.19
Financial Results(決算資料)
Business Results of 2Q/FY2023
2023.05.11
Financial Results(決算資料)
Supplemental Materials of 2Q/FY2023 Consolidated Financial Results
2023.05.11
Financial Results(決算資料)
Financial Results of 2Q/FY2023
2023.05.08
Release(リリース)
Notice of Launch of "Nextstellis™" in Thailand and Commemorative Symposium
2023.03.22
Other(その他)
Fuji Pharma and OLIC support Women's Health Innovation Summit ASIA as event partners
2023.02.09
Financial Results(決算資料)
Supplemental Materials of 1Q/FY2023 Consolidated Financial Results
2023.02.09
Financial Results(決算資料)
Financial Results of 1Q/FY2023